Mark Avagliano
Corporate Officer/Principal chez G1 THERAPEUTICS, INC.
Fortune : 22 091 $ au 30/04/2024
Profil
Mark Avagliano is currently the Chief Business Officer at G1 Therapeutics, Inc. Prior to this, he worked at Pfizer Inc. for 15 years as the Vice President & Head-Corporate Development.
Avagliano has a graduate degree from the University of Oxford and the London School of Economics & Political Science, and an undergraduate degree from Marist College.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
G1 THERAPEUTICS, INC.
0,01% | 13/05/2024 | 5 723 ( 0,01% ) | 22 091 $ | 30/04/2024 |
Postes actifs de Mark Avagliano
| Sociétés | Poste | Début |
|---|---|---|
| G1 THERAPEUTICS, INC. | Corporate Officer/Principal | 30/07/2019 |
Anciens postes connus de Mark Avagliano
| Sociétés | Poste | Fin |
|---|---|---|
| PFIZER, INC. | Corporate Officer/Principal | 01/07/2019 |
Formation de Mark Avagliano
| London School of Economics & Political Science | Graduate Degree |
| University of Oxford | Graduate Degree |
| Marist College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| G1 THERAPEUTICS, INC. | Health Technology |
| PFIZER, INC. | Health Technology |
